By Victoria Bisset and Washington Post staff
It’s fair to say 2023 has been a difficult year in a lot of ways.
In addition to devastating wars — including in Ukraine, the Gaza Strip and Sudan — 2023 also will be Earth’s hottest year in human history, with multiple climate records broken. In the United States in 2023, the highest number of mass killings occurred in any year since at least
2006.
Despite all this, 2023 also was a year with significant positive developments, including in scientific research and medicine — and, throughout the year, moments of genuine connection and humanity shone through the bad news.
Research has indicated that uplifting news can provide an emotional buffer against distressing news and feelings of hopelessness — and even encourage optimism or action. So, in that spirit, here are some of the more uplifting developments you may have missed this year.
The WHO approved a new and affordable malaria vaccine.
In October, the World Health Organization approved a malaria vaccine — only the second time a vaccine against the potentially deadly disease has been created. The WHO said it expects the vaccine, which costs $2-$4 per dose and has been shown
to reduce symptomatic cases by 75 percent after three doses within a year, to be available by the middle of 2024.
More than 600,000 people died of malaria in 2021, with children under 5 representing 80 percent of malaria deaths in Africa. The United States reports about 2,000 malaria cases every year, the Centers for Disease Control and Prevention says, with the majority of them
contracted abroad.
Tedros Adhanom Ghebreyesus, the director general of the WHO, said the announcement gave him “great pleasure. ... I used to dream of the day when we would have a safe and effective vaccine against malaria. Now, we have two.”
The Food and Drug Administration also approved a number of potentially life-changing drugs.
A first-of-its-kind pill to treat postpartum depression, which affects up to 1 in 5 women. The severe and debilitating condition can cause pregnant and
new mothers to experience intense hopelessness and, in rare cases, psychosis — and it can last for years. In the mystery of postpartum depression, the immune system offers clues.
The new drug is taken once a day for two weeks and, unlike the existing treatment of an IV injection that may take as long as 60
hours to administer in a health-care setting, it can be taken at home — greatly improving accessibility, especially for parents caring for a newborn.
While experts say the drug may not be suitable for all women with the condition and won’t be able to treat all aspects of a new mother’s mental health, they
argue that the drug is nonetheless a convenient and fast-acting treatment, and is particularly useful in the early days after a birth, when parents and babies start bonding...READ MORE
If you have trouble clicking through to the link request a reprint.